Can the patient take 150mg fluconazole (Diflucan) with oral micronized progesterone and bioidentical oral estradiol?
Yes, the patient can safely take 150mg fluconazole with oral micronized progesterone and bioidentical oral estradiol—there are no contraindications to this combination, though fluconazole will modestly increase estradiol levels.
Drug Interaction Profile
Fluconazole and Oral Estradiol
The FDA label for fluconazole explicitly addresses this interaction 1. When fluconazole 200mg daily is given with combined oral contraceptives containing ethinyl estradiol, the AUC of ethinyl estradiol increases by 40% and levonorgestrel by 24%. However, the label specifically states that "multiple-dose use of fluconazole at these doses is unlikely to have an effect on the efficacy of the combined oral contraceptive" 1.
For a single 150mg dose (as asked in this question), the effect is even smaller:
- Research demonstrates that a single 150mg fluconazole dose increases ethinyl estradiol maximum concentration by only 8% and AUC by modest amounts 2, 3
- A study specifically evaluating 300mg fluconazole weekly (double the dose in question) with oral contraceptives found only a 24% increase in estradiol AUC and concluded "there is no threat of contraceptive failure because of concomitant fluconazole administration" 2
Clinical significance: This modest increase in estradiol exposure from a single 150mg dose is not clinically concerning and does not require dose adjustment of either medication.
Fluconazole and Oral Micronized Progesterone
No interaction exists between fluconazole and progesterone. The FDA label for fluconazole does not list progesterone as an interacting medication 1. Fluconazole primarily inhibits CYP3A4 and CYP2C9 enzymes, while oral micronized progesterone undergoes first-pass metabolism but is not significantly metabolized by these pathways in a clinically relevant manner 4, 5.
Safety Considerations
What to Monitor
- No specific monitoring is required for this single-dose interaction
- If the patient experiences unusual symptoms (breast tenderness, bloating, mood changes) that might suggest excessive estrogen exposure, these would be transient given the short half-life of fluconazole (approximately 30 hours) 1
Common Pitfalls to Avoid
- Do not discontinue hormone therapy for a single dose of fluconazole—the interaction is minor and self-limited
- Do not reduce estradiol dose preemptively—the increase in exposure is modest and within safe ranges
- Do not confuse this with chronic fluconazole therapy—repeated dosing (e.g., weekly for recurrent candidiasis) would have cumulative effects, but even then the FDA label indicates safety 1
Clinical Context
The 150mg fluconazole dose is the standard treatment for uncomplicated vulvovaginal candidiasis 6. This is a single-dose regimen with excellent efficacy and safety profile. The transient, modest increase in estradiol levels from this one-time interaction poses no meaningful clinical risk and does not warrant any modification of the patient's hormone replacement therapy.
Bottom line: Administer the fluconazole as indicated without adjusting the hormone therapy regimen.